REGENERON PHARMACEUTICALS financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 30/10/2026 | Jun 2026Filed 30/10/2026 | Mar 2026Filed 30/10/2026 | Sep 2025Filed 30/10/2026 | Jun 2025Filed 30/10/2026 | Mar 2025Filed 30/10/2026 | Sep 2024Filed 28/10/2025 | Jun 2024Filed 28/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $5,116 | $4,291 | $3,605 | $3,754 | $3,676 | $3,029 | $3,721 | $3,547 | |
| $1,949 | $1,297 | $727 | $1,460 | $1,392 | $809 | $1,341 | $1,432 | |
| $18.45 | $12.23 | $6.75 | $13.62 | $12.81 | $7.27 | $11.54 | $12.41 | |
| 106 | 106 | 108 | 107 | 109 | 111 | 116 | 115 |
Trend